Sean McLoughlin - Jan 31, 2024 Form 4 Insider Report for HilleVax, Inc. (HLVX)

Role
Chief Operating Officer
Signature
/s/ Paul Bavier, Attorney-in-Fact for Sean McLoughlin
Stock symbol
HLVX
Transactions as of
Jan 31, 2024
Transactions value $
$0
Form type
4
Date filed
2/2/2024, 04:05 PM
Previous filing
Jan 26, 2024
Next filing
Apr 1, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HLVX Stock Option (Right to Buy) Award $0 +250K $0.00 250K Jan 31, 2024 Common Stock 250K $14.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is exercisable as it vests. The option will vest with respect to 25% of the shares of common stock on January 29, 2025, and will vest with respect to the remaining shares in equal monthly installments over the following three years subject to the reporting person's continuous service to the Issuer on the applicable vesting dates.